Shareholders Foundation, Inc.

NASDAQ:ABSI Investor Notice: Investigation over Potential Wrongdoing at Absci Corporation

An investigation on behalf of investors in Absci Corporation (NASDAQ:ABSI) shares over potential wrongdoing at Absci Corporation was announced.

 

San Diego, CA -- (SBWIRE) -- 11/04/2021 -- Certain directors of Absci Corporation are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Absci Corporation (NASDAQ: ABSI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Absci Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders.

Vancouver, WA based Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci Corporation reported that its annual Total Revenue rose from $2.06 million in 2019 to $4.78 million in 2020, and that its Net Loss increased from $6.58 million in 2019 to $14.35 million in 2020.

On or around July 22, 2021, Absci Corporation (NASDAQ: ABSI) conducted its initial public offering ("IPO"), offering 12.5 million shares of common stock priced at $16.00 per share.

Then, on September 7, 2021, Absci Corporation (NASDAQ: ABSI) reported its financial and operating results for the second quarter of 2021. Among other items, Absci Corporation (NASDAQ: ABSI) reported earnings per share and revenue that both fell significantly short of consensus estimates.

Shares of Absci Corporation (NASDAQ: ABSI) declined to as low as $13.68 per share on September 9, 2021.

Those who purchased shares of Absci Corporation (NASDAQ: ABSI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.